United States· US:55150-262_1d8c98fc-8bb8-4caa-a745-5d42ddd2c8ec
Methylprednisolone Sodium Succinate
A methylprednisolon, kombinationen product containing methylprednisolone sodium succinate, registered in United States by Eugia US LLC. The same ATC class is registered in 6 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Methylprednisolon, kombinationen is registered in 6 of 19 countries.
Countries holding a registration under ATC H02BX01 (methylprednisolon, kombinationen), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 4 of them publish a price we can compare per daily dose
Methylprednisolon, kombinationen · ATC H02BX01
6 / 19 countries
- Canada
- Finlandprice
- Netherlands
- Norwayprice
- Switzerlandprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Methylprednisolone Sodium Succinate
- Manufacturer
- Eugia US LLC
- Country
- United States (US)
- ATC code
- H02BX01
- ATC class
- Methylprednisolon, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 1
- ndc11551502620325 VIAL, SINGLE-DOSE in 1 CARTON (55150-262-03) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE
Regulatory notes
Same medicine, other countries
Methylprednisolon, kombinationen in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandMethylprednisolone OrionOrion Corporation
- BelgiumMethylprednisolone Teva 1000 mgTeva Pharma Belgium
- United KingdomMethylprednisolone sodium succinate 125mg powder and solvent for solution for injection vialsPfizer Ltd
- GermanyMethylprednisolon AcisAcis Arzneimittel Gmbh
- CzechiaSOLU-MEDROLPfizer, spol. s r.o., Praha
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Solu-Medrol
- Bulgaria · Метилпреднизолон Чайкафарма
- Czechia · Solu-Medrol
- Germany · Methylprednisolon Hikma, Metypred
- Spain · Urbason
- France · Methylprednisolone Hikma
- United Kingdom (Northern Ireland) · Methylprednisolone Hikma Farmacêutica (Portugal), Methylprednisolone Pfizer
- Hungary · Metilprednizolon Teva
- Italy · Cortrium, Lisamethyle
- Poland · Meprelon
- Portugal · Metilprednisolona Hikma
- Slovakia · Metylprednizolón Hikma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dfaaf4ac-94e7-4986-afb7-89c1c7a46dc4 GET /v1/drugs/dfaaf4ac-94e7-4986-afb7-89c1c7a46dc4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "LEC9GKY20K",
"rxcui": "203189",
"inchikey": "FQISKWAFAHGMGT-SGJOWKDISA-M",
"display_name": "METHYLPREDNISOLONE SODIUM SUCCINATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAMUSCULAR; INTRAVENOUS",
"spl_meta": {
"7092df48-4904-4047-9916-e585417a216f": {
"match": "brand_token",
"title": "METHYLPREDNISOLONE TABLET [BLUEPOINT LABORATORIES]",
"spl_version": "3",
"published_date": "2026-05-25"
}
},
"productid": "55150-262_1d8c98fc-8bb8-4caa-a745-5d42ddd2c8ec",
"productndc": "55150-262",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"orange_book": {
"appl_no": "207667",
"products": [
{
"rs": false,
"rld": false,
"te_code": null,
"strength": "EQ 40MG BASE/VIAL",
"product_no": "001",
"approval_date": "Dec 15, 2015"
},
{
"rs": false,
"rld": false,
"te_code": null,
"strength": "EQ 125MG BASE/VIAL",
"product_no": "002",
"approval_date": "Dec 15, 2015"
},
{
"rs": false,
"rld": false,
"te_code": null,
"strength": "EQ 500MG BASE/VIAL",
"product_no": "003",
"approval_date": "Dec 15, 2015"
},
{
"rs": false,
"rld": false,
"te_code": null,
"strength": "EQ 2GM BASE/VIAL",
"product_no": "004",
"approval_date": "Dec 15, 2015"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "METHYLPREDNISOLONE SODIUM SUCCINATE",
"shortage_reason": "Methylprednisolone Acetate Injection",
"shortage_status": "current",
"proprietary_name": "Methylprednisolone Sodium Succinate",
"active_ingred_unit": "mg/1",
"application_number": "ANDA207667",
"marketing_category": "ANDA",
"nonproprietary_name": "Methylprednisolone Sodium Succinate",
"start_marketing_date": "20151215",
"active_numerator_strength": "40"
}See everything about methylprednisolon, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.